166 related articles for article (PubMed ID: 31937618)
1. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma
Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM; Søiland H; Gogineni K; Manne U; Rida P; Rakha EA; Aneja R
Clin Cancer Res; 2020 Jun; 26(12):2898-2907. PubMed ID: 31937618
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategy for ductal carcinoma in situ patients according to Van Nuys Prognostic Index.
Andretta M; Scomersi S; Urbani M; Bortul M
Ann Ital Chir; 2014; 85(3):254-9. PubMed ID: 25074533
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
[TBL] [Abstract][Full Text] [Related]
6. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.
Gilleard O; Goodman A; Cooper M; Davies M; Dunn J
World J Surg Oncol; 2008 Jun; 6():61. PubMed ID: 18564426
[TBL] [Abstract][Full Text] [Related]
7. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
8. Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.
de Mascarel I; Bonichon F; MacGrogan G; de Lara CT; Avril A; Picot V; Durand M; Mauriac L; Trojani M; Coindre JM
Breast Cancer Res Treat; 2000 May; 61(2):151-9. PubMed ID: 10942101
[TBL] [Abstract][Full Text] [Related]
9. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
[TBL] [Abstract][Full Text] [Related]
10. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
[TBL] [Abstract][Full Text] [Related]
13. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
15. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
Pilewskie M; Olcese C; Eaton A; Patil S; Morris E; Morrow M; Van Zee KJ
Ann Surg Oncol; 2014 May; 21(5):1552-60. PubMed ID: 24385207
[TBL] [Abstract][Full Text] [Related]
16. Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand.
Whitfield R; Kollias J; de Silva P; Turner J; Maddern G
ANZ J Surg; 2012; 82(7-8):518-23. PubMed ID: 22758922
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
[TBL] [Abstract][Full Text] [Related]
18. Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).
Altintas S; Toussaint J; Durbecq V; Lambein K; Huizing MT; Larsimont D; Van Marck E; Vermorken JB; Tjalma WA; Sotiriou C
Breast J; 2011; 17(4):343-51. PubMed ID: 21645166
[TBL] [Abstract][Full Text] [Related]
19. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
[TBL] [Abstract][Full Text] [Related]
20. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
Kelley L; Silverstein M; Guerra L
Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
